Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11753463 Therapeutic targeting of non-cellular structures

Patent 11753463 was granted and assigned to Orionis Biosciences on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Orionis Biosciences
Orionis Biosciences
Date Filed
May 12, 2017
Date of Patent
September 12, 2023
Patent Application Number
16301299
Patent Citations
‌
US Patent 9534056 Engineered TAA antibody-TNFSF member ligand fusion molecules
‌
US Patent 9732135 Targeting of human interferon antagonists
‌
US Patent 9878014 Targeted human-interferon fusion proteins
‌
US Patent 9914759 Targeted modified TNF family members
‌
US Patent 10035835 Targeted modified TNF family members
‌
US Patent 10072059 Targeting of human interferon antagonists
‌
US Patent 10407480 Targeted modified TNF family members
‌
US Patent 10787493 Targeted modified TNF family members
‌
US Patent 10988538 Bispecific signaling agents and uses thereof
‌
US Patent 10906985 Targeted engineered interferon and uses thereof
•••
Patent Inventor Names
Nikolai Kley
Leander Huyghe
Anje Cauwels
Jan Tavernier
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11753463
Patent Primary Examiner
‌
Ilia I Ouspenski

Find more entities like US Patent 11753463 Therapeutic targeting of non-cellular structures

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo